Cardiol Therapeutics Correlations
| CRDL Stock | CAD 1.42 0.10 6.58% |
The current 90-days correlation between Cardiol Therapeutics and Medicenna Therapeutics Corp is 0.11 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardiol Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardiol Therapeutics Class moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Cardiol Therapeutics Correlation With Market
Significant diversification
The correlation between Cardiol Therapeutics Class and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cardiol Therapeutics Class and DJI in the same portfolio, assuming nothing else is changed.
Cardiol |
The ability to find closely correlated positions to Cardiol Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardiol Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardiol Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardiol Therapeutics Class to buy it.
Moving together with Cardiol Stock
Moving against Cardiol Stock
Related Correlations Analysis
| 0.52 | -0.64 | -0.33 | -0.67 | LABS | ||
| 0.52 | -0.19 | -0.06 | -0.12 | AVCN | ||
| -0.64 | -0.19 | 0.4 | 0.55 | MDNA | ||
| -0.33 | -0.06 | 0.4 | 0.58 | CWEB | ||
| -0.67 | -0.12 | 0.55 | 0.58 | PCLO | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cardiol Stock performing well and Cardiol Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cardiol Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LABS | 4.38 | 0.88 | 0.10 | (0.65) | 4.11 | 14.29 | 38.89 | |||
| AVCN | 3.87 | 0.05 | 0.01 | (0.05) | 4.63 | 5.71 | 33.33 | |||
| MDNA | 2.64 | (0.83) | 0.00 | (1.01) | 0.00 | 3.94 | 16.18 | |||
| CWEB | 3.93 | 0.44 | 0.04 | 0.89 | 4.64 | 14.29 | 35.42 | |||
| PCLO | 4.35 | (0.45) | 0.00 | 0.27 | 0.00 | 10.00 | 27.62 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cardiol Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Cardiol Therapeutics Corporate Management
Elected by the shareholders, the Cardiol Therapeutics' board of directors comprises two types of representatives: Cardiol Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardiol. The board's role is to monitor Cardiol Therapeutics' management team and ensure that shareholders' interests are well served. Cardiol Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardiol Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.